Most HR leaders don't have a wellness problem. They have a budget approval problem.
The data on workplace wellness is extensive. The peer-reviewed research is real. And according to EPIC's 2026 Workplace Wellness Survey of 238 benefits leaders, the number one barrier to wellness investment isn't skepticism about whether it works. It's getting finance to say yes. Budget constraints and lack of time top the list. Clear ROI and affordability top the list of what would actually move the needle.
That gap between what HR knows and what the CFO will fund is what this guide is designed to close. What follows is a practical, finance-ready reference: the benchmarks that hold up to scrutiny, the metrics worth tracking, the hidden costs most employee wellness ROI models miss, and a presentation framework that speaks the language finance actually responds to.
Why Standard Wellness Pitches Fail Finance Reviews.
Walk into a CFO's office with employee satisfaction scores and participation rates, and the conversation is over before it starts. Finance evaluates every line item the same way: what does it cost, what does it return, what is the risk, and how long until we see results?
Most wellness pitches don't answer those questions. They lead with the wrong metrics, skip the baseline cost anchors, and make claims that don't survive scrutiny. The result is a proposal that feels soft in a room full of spreadsheets. The good news is the underlying evidence is strong enough to build a rigorous case. The work is in the packaging.
The Financial Evidence Behind Employee Wellness ROI.
The Foundational Numbers
The most cited study in the field comes from a 2010 meta-analysis published in Health Affairs by Katherine Baicker, David Cutler, and Zirui Song of Harvard University. Drawing on 36 peer-reviewed studies, the research found medical costs fall approximately $3.27 for every dollar invested in wellness programs, and absenteeism costs fall approximately $2.73 per dollar spent. These numbers appear across virtually every serious ROI discussion in the field because no stronger research has replaced them.
It's worth being honest about the caveats, both because they're real and because acknowledging them builds credibility with a finance audience. Dr. Baicker herself has since noted that the 2010 analysis relied on older studies and that more rigorous research is needed. A separate meta-analysis published in the American Journal of Health Promotion found negative ROI in randomized controlled trials, partly because observational studies tend to overstate returns when healthier, more motivated employees self-select into wellness programs.
The practical framing for a CFO: the Harvard figures are a credible benchmark, not a guarantee. Program design determines results. Use the numbers as a starting point for projections, not a closing argument.
Harvard Meta-Analysis, Health Affairs
The RAND PepsiCo Study: Where ROI Is Strongest
The most rigorous real-world test of wellness ROI comes from RAND's seven-year PepsiCo study, which tracked over 67,000 employees. The overall program returned $1.50 per dollar invested. But the breakdown is where the practical insight lives.
Disease management programs targeting employees with existing chronic conditions returned $3.78 per dollar invested, driven by a 29% reduction in hospital admissions. Lifestyle management programs targeting the general workforce returned only $0.50 per dollar when measured strictly on healthcare costs, though they did produce meaningful reductions in absenteeism.
The implication for CFO conversations is significant: the strength of the financial case depends heavily on who the program serves. Organizations with meaningful populations managing chronic conditions such as hypertension, diabetes, and obesity have the clearest and fastest path to positive ROI. General wellness promotion for a healthy workforce takes longer to show financial returns, though it still generates real value through turnover and engagement.
The Johnson & Johnson Benchmark
For CFOs who respond to concrete dollar figures, Johnson & Johnson's internal wellness program offers a useful reference point. Harvard Business Review researchers estimated the program generated approximately $250 million in savings over a decade, roughly $2.71 per dollar invested in combined medical and absenteeism savings. It's worth noting the primary methodology report isn't publicly available, so this figure is best used as a directional example rather than a primary source.
The True Cost of Doing Nothing: Healthcare Premium Benchmarks.
A CFO who declines to fund a wellness program hasn't made a cost-neutral decision. Healthcare premiums are rising at a rate that makes the status quo increasingly expensive. Average family premiums for employer-sponsored insurance reached $26,993 in 2025, up 6% from the prior year, according to KFF's 2025 Employer Health Benefits Survey. That's the third consecutive year of increases at that rate, well above general inflation and wage growth.
For an organization with 500 employees, a 6% increase on family coverage represents a six-figure annual cost increase from doing nothing. Framed that way, the question in the CFO meeting isn't "should we invest in wellness?" It's "how do we manage a cost that's already growing?"
Vitality's 2024 research places average medical claims savings at $462 per employee engaged in wellbeing programs annually. Deloitte research puts absenteeism costs at $3,600 per hourly employee and $2,650 per salaried employee per year. These per-employee figures make it straightforward to build an ROI model tailored to the actual size of any workforce.

Hidden Costs Most Employee Wellness ROI Models Miss.
Healthcare claims are the most visible cost, but they're not the whole picture. Two categories of costs are frequently left out of wellness ROI presentations, and both are large enough to materially change the math.
Turnover
SHRM estimates replacement costs at 50% to 200% of annual salary, depending on role level. For a $60,000 salaried employee, that's $30,000 to $120,000 per departure, with hard costs like recruiting and onboarding representing only 30 to 40% of the total. The rest is soft: lost institutional knowledge, declining morale on the remaining team, and manager time diverted to hiring.
The link between wellness and retention is directionally well-supported. McKinsey research found employees with mental health and wellbeing challenges are four times more likely to want to leave their organization. For mid-sized organizations with meaningful voluntary turnover, even a modest retention improvement from a wellness program can generate returns that exceed the cost of the program itself.
Presenteeism
Absenteeism is visible. It shows up in time-tracking data. Presenteeism is not. It's the productivity lost when employees show up but can't fully function, and CDC-cited research estimates it costs U.S. employers approximately $150 billion annually. The Integrated Benefits Institute calculates that poor health overall costs U.S. employers $575 billion and 1.5 billion days of lost productivity per year.
In a CFO conversation, the question isn't whether these costs exist. It's whether the organization has a plan to address them. Presenteeism rarely appears on anyone's budget, which means wellness programs that reduce it generate real value that never gets credited to the ROI model.
Gallup's 2026 workplace report found global employee engagement dropped to just 20% in 2025, costing the world economy an estimated $10 trillion in lost productivity. Disengaged employees are also significantly more likely to be actively job searching, compounding the turnover cost above.
Wellness Program Metrics That Hold Up to Finance Scrutiny.
Most wellness programs measure the wrong things. Participation rates are easy to track and easy to present, but they're what finance calls a leading input, not an outcome. A CFO who asks "what did we get for that?" and hears "92% enrollment" hasn't received an answer.
The metrics that survive finance scrutiny fall into three categories.
Healthcare claims costs per employee year-over-year, short-term disability frequency, workers' compensation claims. A 2014 meta-analysis found wellness programs produced a 32% average reduction in workers' comp and disability costs. Requires a pre-program baseline to be meaningful.
Preventive care completion rates, EAP utilization, active program participation rather than just enrollment. These are leading indicators that give finance something to review at 6 and 12 months before claims data reflects the program's impact.
Voluntary turnover rate, absenteeism rate, employee engagement scores. The strongest methodology is cohort analysis, tracking participants versus non-participants over the same period. It produces data finance can actually engage with.
One timing note worth stating plainly in any CFO presentation: most programs don't generate measurable financial ROI in year one. The Harvard meta-analysis, RAND data, and Johnson & Johnson case study all reflect programs running three to ten years. Proposing a measurement plan with defined 12, 24, and 36 month milestones rather than year-one guarantees signals analytic rigor and earns more credibility than projections that don't account for ramp time.
How to Structure a CFO-Ready Wellness Program Business Case.
The structure that works is the same one finance uses for any capital investment proposal.
Lead with the ask and the expected return. In the first 30 seconds. Not the background, not the research. The number and what it costs to get there. Finance listens differently when the return is on the table first.
Anchor to current costs. Before presenting program costs, show what the organization is already spending. Healthcare cost per employee. Estimated absenteeism cost using Deloitte's $2,650 to $3,600 per-employee benchmarks. A rough turnover cost estimate based on SHRM's 50 to 200% salary replacement figure and actual voluntary turnover data. This reframes the wellness investment as a response to existing costs, not a new discretionary expense.
Present conservative projections using peer-reviewed sources. Use the lower bound of published research for conservative estimates. A program focused on chronic disease management can conservatively use RAND's $1.50 per dollar figure. A well-designed multi-year program can project toward the Harvard $3.27 benchmark. Show the range. Explain the assumptions. Let the CFO test the model rather than take it on faith. As Selerix's 2025 benefits ROI guide notes, benchmarking against industry peers reframes the investment as a competitive decision, not a soft benefit.
Three-scenario modeling — conservative, base, and optimistic — using the lower bound of published research for the conservative case signals the proposal has been stress-tested. CFOs respond better to a range with explained assumptions than to a single number that looks too good.
Separate hard-dollar returns from directional value. The VOI (Value on Investment) framework supplements hard-dollar ROI with outcomes that are real but harder to isolate: engagement scores, benefits satisfaction, and absenteeism trends among participants versus non-participants. CFOs trained in finance will respond better to acknowledged uncertainty than inflated precision. Separating the two categories is a credibility move.
Propose a measurement plan, not a guarantee. Define what will be tracked, how baselines will be established, and what the reporting cadence looks like. Three-scenario modeling using the lower bound of published research for the conservative case signals that the proposal has been stress-tested.
What the Research Agrees On: Wellness ROI Consensus.
A few things in the wellness ROI literature are not seriously contested. Healthcare claims fall when wellness programs run for three or more years with strong participation. Disease management consistently delivers positive ROI. The RAND PepsiCo data and Harvard meta-analysis both confirm it. Absenteeism decreases with well-designed programs. Turnover is reduced among participants, with the McKinsey finding on wellbeing challenges providing the clearest causal link.
Healthcare costs are rising faster than inflation for the third consecutive year. And budget constraints, not skepticism about wellness value, remain the primary barrier to investment.
The honest caveat worth including in any CFO presentation: lifestyle management programs targeting healthy employees frequently return less than $1 per $1 invested when measured on healthcare costs alone in the short term. The aggregate ROI range in published research runs from $1.50 (RAND PepsiCo overall) to $6.00 (high-risk targeting, HBR analysis). Programs that target high-risk or chronic disease populations, establish pre-program baselines, track financial outcomes rather than participation alone, and run for three or more years consistently outperform programs that don't. The difference between wellness as an expense and wellness as an investment is almost entirely execution.
Building Your CFO-Ready Employee Wellness Business Case.
A presentation that earns approval looks something like this.
Start with the baseline. What are healthcare premiums costing now, and what does a 6% annual increase mean in dollar terms over three years? What is the estimated cost of voluntary turnover at current rates? What does absenteeism cost the organization annually using the Deloitte benchmarks?
Layer in the program investment. What does the employee wellness solution cost per employee per year? What is the total annual investment?
Build the ROI projection using conservative assumptions. For a workforce with meaningful chronic condition prevalence, RAND's $1.50 per dollar return is a defensible floor. At the $3.27 Harvard benchmark, what does the three-year return look like? Show both. Add the turnover and presenteeism value separately, clearly labeled as directional. Even conservative assumptions about retention improvement produce significant dollar figures at scale.
Propose a measurement plan. Baseline metrics established before launch. Reporting at 12, 24, and 36 months. Cohort analysis comparing participants to non-participants. Defined milestones for when the program can reasonably be expected to show financial returns.
The framework above works for any program. The differentiator is what you can actually prove once it's running. Avidon Health's outcome data, including a 38.1% tobacco quit rate from a San Diego State University controlled study and a 96% participant recommendation rate across 7,000-plus exit surveys, gives HR leaders the proof layer that turns a strong business case into a defensible one. When finance asks "what evidence do we have that employees will actually use this?", those are the numbers that answer it.
